"Message in the Platelet" - More than just vestigial mRNA!

Platelets

Volumn 19, Issue 6, 2008, Pages 395-404

  Harrison, Paul ^a   Goodall, Alison H ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

mRNA; Platelet; Platelet heterogeneity; Platelet transcriptome; Reticulated platelets

Indexed keywords

CELL PROTEIN; MESSENGER RNA; TRANSCRIPTOME;

GENOME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; THROMBOCYTE;

BLOOD PLATELETS; HUMANS; RNA, MESSENGER;

MAMMALIA;

EID: 54249111476     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100801990582     Document Type: Review

References (94)

1. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.
2. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227-1234.
3. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005;115:3339-3347.
4. Italiano JE Jr, Shivdasani RA. Megakaryocytes and beyond: The birth of platelets. J Thromb Haemost 2003;1:1174-1182.
5. Italiano JE Jr, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999;147:1299-1312.
6. Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007;317:1767-1770.
7. Geddis AE, Kaushansky K. Immunology. The root of platelet production. Science 2007;317:1689-1691.
8. Zucker-Franklin D. Megakaryocyte and platelet structure in thrombocytopoiesis: The effect of cytokines. Stem Cells 1996;14(Suppl. 1):1-17.
9. Ts'ao CH. Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol 1971;8:134-140.
10. Booyse FM, Rafelson ME Jr. Studies on human platelets. I. synthesis of platelet protein in a cell-free system. Biochim Biophys Acta 1968;166:689-697.
11. Booyse FM, Hoveke TP, Rafelson ME Jr. Studies on human platelets. II. Protein synthetic activity of various platelet populations. Biochim Biophys Acta 1968;157:660-663.
12. Philipp CS, Remmler J, Zucker-Franklin D. The effects of Mpl-ligand, interleukin-6 and interleukin-11 on megakaryocyte and platelet alpha-granule proteins. Thromb Haemost 1998;80:968-975.
13. Jarvis G. Platelets, polysomes and proteins. Trends Pharmacol Sci 2001;22:498.
14. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-646.
15. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995;23:996-1001.
16. Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood 1995;85:1822-1825.
17. Robinson M, Machin S, Mackie I, Harrison P. In vivo biotinylation studies: Specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol 2000;108:859-864.
18. Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol 1969;17:225-229.
19. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990;75:116-121.
20. Harrison P, Robinson MS, Mackie IJ, Machin SJ. Reticulated platelets. Platelets 1997;8:379-383.
21. Ault KA. Flow cytometric measurement of platelet function and reticulated platelets. Ann N Y Acad Sci 1993;677:293-308.
22. Richards EM, Baglin TP. Quantitation of reticulated platelets: Methodology and clinical application. Br J Haematol 1995;91:445-451.
23. Richards EM, Jestice HK, Mahendra P, Scott MA, Marcus RE, Baglin TP. Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: Implications for marrow reconstitution and the use of thrombopoietin. Bone Marrow Transplant 1996;17:1029-1033.
24. Saxon BR, Mody M, Blanchette VS, Freedman J. Reticulated platelet counts in the assessment of thrombocytopenic disorders. Acta Paediatr Suppl 1998;424:65-70.
25. Matic GB, Chapman ES, Zaiss M, Rothe G, Schmitz G. Whole blood analysis of reticulated platelets: Improvements of detection and assay stability. Cytometry 1998;34:229-234.
26. Rinder HM, Munz UJ, Ault KA, Bonan JL, Smith BR. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med 1993;117:606-610.
27. Robinson MS, Mackie IJ, Khair K, et al. Flow cytometric analysis of reticulated platelets: Evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. Br J Haematol 1998;100:351-357.
28. Jimenez MM, Guedan MJ, Martin LM, Campos JA, Martinez IR, Vilella CT. Measurement of reticulated platelets by simple flow cytometry: An indirect thrombocytopoietic marker. Eur J Intern Med 2006;17:541-544.
29. Wang C, Smith BR, Ault KA, Rinder HM. Reticulated platelets predict platelet count recovery following chemotherapy. Transfusion 2002;42:368-374.
30. Balduini CL, Noris P, Spedini P, Belletti S, Zambelli A, Da Prada GA. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy. Br J Haematol 1999;106:202-207.
31. Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int J Lab Hematol 2007;29:77-91.
32. Watanabe K, Takeuchi K, Kawai Y, Ikeda Y, Kubota F, Nakamoto H. Automated measurement of reticulated platelets in estimating thrombopoiesis. Eur J Haematol 1995;54:163-171.
33. Watanabe K, Kawai Y, Takeuchi K. [Reticulated platelets-automated measurement and clinical utility]. Rinsho Ketsueki 1995;36:267-272.
34. Briggs C, Harrison P, Grant D, Staves J, Machin SJ. New quantitative parameters on a recently introduced automated blood cell counter-the XE 2100. Clin Lab Haematol 2000;22:345-350.
35. Segal HC, Briggs C, Kunka S, et al. Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. Br J Haematol 2005;128:520-525.
36. Zucker ML, Murphy CA, Rachel JM, et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol 2006;12:125-130.
37. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93-99.
38. Briggs C, Hart D, Kunka S, Oguni S, Machin SJ. Immature platelet fraction measurement: A future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med 2006;16:101-109.
39. Abe Y, Wada H, Tomatsu H, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006;118:463-469.
40. Kickler TS, Oguni S, Borowitz MJ. A clinical evaluation of high fluorescent platelet fraction percentage in thrombocytopenia. Am J Clin Pathol 2006;125:282-287.
41. Newman PJ, Gorski J, White GC, Gidwitz S, Cretney CJ, Aster RH. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988;82:739-743.
42. Belloc F, Hourdille P, Boisseau MR, Bernard P. Protein synthesis in human platelets correlation with platelet size. Nouv Rev Fr Hematol 1982;24:369-373.
43. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 1987;164:189-195.
44. Steiner M, Baldini M. Protein synthesis in aging blood platelets. Blood 1969;33:628-633.
45. Sottile J, Mosher DF, Fullenweider J, George JN. Human platelets contain mRNA transcripts for platelet factor 4 and actin. Thromb Haemost 1989;62:1100-1102.
46. Fink L, Holschermann H, Kwapiszewska G, et al. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb Haemost 2003;90:749-756.
47. Wicki AN, Walz A, Gerber-Huber SN, Wenger RH, Vornhagen R, Clemetson KJ. Isolation and characterization of human blood platelet mRNA and construction of a cDNA library in lambda gt11. Confirmation of the platelet derivation by identification of GPIb coding mRNA and cloning of a GPIb coding cDNA insert. Thromb Haemost 1989;61:448-453.
48. Wenger RH, Wicki AN, Walz A, Kieffer N, Clemetson KJ. Cloning of cDNA coding for connective tissue activating peptide III from a human platelet-derived lambda gt11 expression library. Blood 1989;73:1498-1503.
49. Djaffar I, Vilette D, Bray PF, Rosa JP. Quantitative isolation of RNA from human platelets. Thromb Res 1991;62:127-135.
50. Macaulay IC, Carr P, Farrugia R, Watkins NA. Analysing the platelet transcriptome. Vox Sang 2004;87(Suppl. 2):42-46.
51. Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, Watkins NA. Platelet genomics and proteomics in human health and disease. J Clin Invest 2005;115:3370-3377.
52. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003;101:2285-2293.
53. Dittrich M, Birschmann I, Pfrang J, et al. Analysis of SAGE data in human platelets: Features of the transcriptome in an anucleate cell. Thromb Haemost 2006;95:643-651.
54. Bugert P, Kluter H. Profiling of gene transcripts in human platelets: An update of the platelet transcriptome. Platelets 2006;17:503-504.
55. Kim HL. Comparison of oligonucleotide-microarray and serial analysis of gene expression (SAGE) in transcript profiling analysis of megakaryocytes derived from CD34+ cells. Exp Mol Med 2003;35:460-466.
56. Shim MH, Hoover A, Blake N, Drachman JG, Reems JA. Gene expression profile of primary human CD34pCD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol 2004;32:638-648.
57. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 2007;109:3260-3269.
58. Ouwehand WH. Platelet genomics and the risk of atherothrombosis. J Thromb Haemost 2007;5(Suppl. 1):188-195.
59. McRedmond JP, Park SD, Reilly DF, et al. Integration of proteomics and genomics in platelets: A profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 2004;3:133-144.
60. Nanda N, Bao M, Lin H, et al. Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem 2005;280:24680-24689.
61. Dittrich M, Birschmann I, Stuhlfelder C, et al. Understanding platelets. Lessons from proteomics, genomics and promises from network analysis. Thromb Haemost 2005;94:916-925.
62. Healy AM, Pickard MD, Pradhan AD, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006;113:2278-2284.
63. Raghavachari N, Xu X, Harris A, et al. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 2007;115:1551-1562.
64. Wang L, Erling P, Bengtsson AA, Truedsson L, Sturfelt G, Erlinge D. Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus. J Thromb Haemost 2004;2:1436-1442.
65. Tenedini E, Fagioli ME, Vianelli N, et al. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. Blood 2004;104:3126-3135.
66. Krishnan U, Goodall AH, Bugert P. Letter by Krishnan et al regarding article, ''Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2007;115:e186.
67. Bugert P, Dugrillon A, Gunaydin A, Eichler H, Kluter H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 2003;90:738-748.
68. Martens L, Van DP, Van DJ, et al. The human platelet proteome mapped by peptide-centric proteomics: A functional protein profile. Proteomics 2005;5:3193-3204.
69. Jones CI, Garner SF, Angenent W, et al. Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost 2007;5:1756-1765.
70. Weyrich AS, Dixon DA, Pabla R, et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998;95:5556-5561.
71. Pabla R, Weyrich AS, Dixon DA, et al. Integrin-dependent control of translation: Engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol 1999;144:175-184.
72. Weyrich AS, Denis MM, Schwertz H, et al. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 2007;109:1975-1983.
73. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004;104:3943-3948.
74. Weyrich AS, Lindemann S, Tolley ND, et al. Change in protein phenotype without a nucleus: Translational control in platelets. Semin Thromb Hemost 2004;30:491-498.
75. Roth GJ, Hickey MJ, Chung DW, Hickstein DD. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun 1989;160:705-710.
76. Lindemann S, Tolley ND, Eyre JR, Kraiss LW, Mahoney TM, Weyrich AS. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem 2001;276:33947-33951.
77. Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: Signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005;122:379-391.
78. Konig H, Matter N, Bader R, Thiele W, Muller F. Splicing segregation: The minor spliceosome acts outside the nucleus and controls cell proliferation. Cell 2007;131:718-729.
79. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154:485-490.
80. Thon JN, Devine DV. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007;47:2260-2270.
81. Schwertz H, Tolley ND, Foulks JM, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006;203:2433-2440.
82. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost 2006;32:11-23.
83. Losche W. Platelets and tissue factor. Platelets 2005;16:313-319.
84. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585-1598.
85. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171-178.
86. Panes O, Matus V, Saez CG, Quiroga T, Pereira J, Mezzano D. Human platelets synthesize and express functional tissue factor. Blood 2007;109:5242-5250.
87. Weyrich AS, Schwertz H, Mackman N. Platelet tissue factor comes of age. Blood 2007;109:5069-5070.
88. Lindemann S, Gawaz M. The active platelet: Translation and protein synthesis in an anucleate cell. Semin Thromb Hemost 2007;33:144-150.
89. Brown SB, Clarke MC, Magowan L, Sanderson H, Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J Biol Chem 2000;275:5987-5996.
90. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003;43:857-866.
91. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173-1186.
92. Qi B, Hardwick JM. A Bcl-xL timer sets platelet life span. Cell 2007;128:1035-1036.
93. McRedmond J. Finding drug targets through analysis of the platelet transcriptome. Curr Pharm Des 2007;13:2662-2667.
94. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an Immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93-99.